Integra Returns to Growth on Backlogged Procedures

Integra LifeSciences reported 3Q20 orthopedic revenue of USD $21.9 million, +5.1% vs. 3Q19. In the second quarter, the company noted that its orthopedics franchise showed the strongest improvement among all of its businesses as surgeons worked through backlogged procedures. That momentum carried into the third quarter as the backlog work...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us